13
03, 2024
27
02, 2024
20
02, 2024
20
02, 2024
14
02, 2024
Lorenza Rimassa et al., Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition
adlitterio663392024-02-14T14:34:18+01:00
11
02, 2024
2
02, 2024
27
01, 2024
19
01, 2024
17
01, 2024